Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represented Verdane Capital in the divestment of Wireless Maingate
Mandate

Vinge represented Verdane Capital in the divestment of Wireless Maingate

December 23, 2014

Vinge represented Verdane Capital VI in the divestment of Wireless Maingate AB (”Maingate”) to the NASDAQ-listed Canadian company Sierra Wireless, Inc. for a purchase price of USD 90 million.

Maingate is a pioner within the M2M field, i.e. mobile communication between devices, and has a market leading position in the Nordic market. Sierra Wireless is a world leader within the field of equipment and services for M2M communication.

Vinges team consisted of partner Jesper Ottergren together with associates Anna Edström, Kristoffer Franzkeit and Cecilia Cronqvist

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026